Related Experiment Videos
The mesangial matrix in the normal and sclerotic glomerulus
1Division of Nephrology, Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Kidney International. Supplement
|February 1, 1994
Summary
Mesangial sclerosis involves changes in the glomerular extracellular matrix. Type VIII collagen may play a role in the mesangial matrix structure and disease progression.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- Mesangial sclerosis is a common outcome in glomerular diseases.
- The role of extracellular matrix (ECM) molecules in mesangial matrix (MM) structure and function is not fully understood.
- Non-renal ECMs, like the cornea, offer insights into matrix organization.
Purpose of the Study:
- To investigate the role of type VIII collagen in the glomerulus.
- To understand how ECM components influence the three-dimensional structure and function of the mesangial matrix.
- To explore the changes in MM composition during chronic glomerular disease.
Main Methods:
- Structural analysis of the mesangial matrix.
- Analysis of extracellular matrix molecule expression in glomerular diseases.
- Comparison of renal and non-renal extracellular matrix organization.
Main Results:
- Mesangial matrix components are regionally organized into subcompartments.
- Type VIII collagen is present in mesangial cells and glomeruli, potentially existing as polymers or monomers.
- Diseased mesangial matrix shows overexpression of normal components and de novo expression of fibrillar collagens.
- Early disease involves enhanced proteoglycan expression, leading to increased mesangial volume and subsequent fibrillar collagen production.
Conclusions:
- Type VIII collagen's conformation may dictate its function within the glomerulus.
- Altered ECM composition, particularly increased proteoglycans and fibrillar collagens, contributes to a noncompliant mesangial matrix in chronic glomerular disease.
- Understanding MM structure and ECM dynamics is crucial for deciphering glomerular destruction pathways.